Vaccination of adolescents with chronic medical conditions: Special considerations and strategies for enhancing uptake

References

• Berry JG, Bloom S, Foley S, Palfrey JS. Health inequity in children and youth with chronic health conditions. Pediatrics Dec 2010; 126 Suppl 3:S111-9; PMID:21123473
   PubMedGoogle Scholar
• Newacheck PW, Kim SE. A national profile of health care utilization and expenditures for children with special health care needs. Arch Pediat Adolesc Med Jan 2005; 159(1):10-7; PMID:15630052; http://dx.doi.org/10.1001/archpedi.159.1.10
   PubMed Web of Science ®Google Scholar
• Perrin JM, Bloom SR, Gortmaker SL. The increase of childhood chronic conditions in the United States. Jama Jun 27 2007; 297(24):2755-9; PMID:17595277; http://dx.doi.org/10.1001/jama.297.24.2755
   PubMed Web of Science ®Google Scholar
• Suris JC, Parera N. Sex, drugs and chronic illness: health behaviours among chronically ill youth. Eur J Public Health Oct 2005; 15(5):484-8; PMID:16162596; http://dx.doi.org/10.1093/eurpub/cki001
   PubMed Web of Science ®Google Scholar
• Denny S, de Silva M, Fleming T, Clark T, Merry S, Ameratunga S, Milfont T, Farrant B, Fortune SA. The prevalence of chronic health conditions impacting on daily functioning and the association with emotional well-being among a national sample of high school students. J Adolesc Health: Off Pub Soc Adolesc Med Apr 2014; 54(4):410-5; PMID:24210897; http://dx.doi.org/10.1016/j.jadohealth.2013.09.010
   PubMed Web of Science ®Google Scholar
• Berntsson LT, Kohler L. Long-term illness and psychosomatic complaints in children aged 2-17 years in the five Nordic countries. Comparison between 1984 and 1996. Eur J Public Health Mar 2001; 11(1):35-42; PMID:11276569; http://dx.doi.org/10.1093/eurpub/11.1.35
   PubMed Web of Science ®Google Scholar
• Miauton L, Narring F, Michaud PA. Chronic illness, life style and emotional health in adolescence: results of a cross-sectional survey on the health of 15-20-year-olds in Switzerland. Eur J Pediat Oct 2003; 162(10):682-9; PMID:12915981; http://dx.doi.org/10.1007/s00431-003-1179-x
   PubMed Web of Science ®Google Scholar
• Sawyer SM, Drew S, Yeo MS, Britto MT. Adolescents with a chronic condition: challenges living, challenges treating. Lancet Apr 28 2007; 369(9571):1481-9; PMID:17467519; http://dx.doi.org/10.1016/S0140-6736(07)60370-5
   PubMed Web of Science ®Google Scholar
• Davis MM, Brosco JP. Being specific about being special: defining children's conditions and special health care needs. Arch Pediat Adolesc Med Oct 2007; 161(10):1003-5; PMID:17909146; http://dx.doi.org/10.1001/archpedi.161.10.1003
   PubMed Web of Science ®Google Scholar
• van der Lee JH, Mokkink LB, Grootenhuis MA, Heymans HS, Offringa M. Definitions and measurement of chronic health conditions in childhood: a systematic review. Jama Jun 27 2007; 297(24):2741-51; PMID:17595275; http://dx.doi.org/10.1001/jama.297.24.2741
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 years: United States, 2015. http://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf. Accessed 29 May 2015.
   Google Scholar
• World Health Organization. Summary of WHO position papers: recommendations for routine immunization, 2015. http://www.who.int/immunization/policy/Immunization_routine_table1.pdf. Accessed 29 May 2015.
   Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA Jr, Unger ER, Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep Aug 29 2014; 63(RR-05):1-30; PMID:25167164
   PubMed Web of Science ®Google Scholar
• World Health Organization. Human papillomavirus vaccines: WHO position paper, October 2014. Weekly Epidemiol Rec 2014; 89 (43):465-92
   PubMedGoogle Scholar
• Klosky JL, Foster RH, Hodges J, Peasant C, Gamble H, McDermott MJ, Rao P. Human papillomavirus vaccination and the primary prevention of cancer: implications for survivors of childhood cancer. Stud Health Technol Inform 2012; 172:33-42; PMID:22910499
   PubMedGoogle Scholar
• Malouf MA, Hopkins PM, Singleton L, Chhajed PN, Plit ML, Glanville AR. Sexual health issues after lung transplantation: importance of cervical screening. J Heart Lung Transplant: Off Pub Int Soc Heart Transplant Jul 2004; 23(7):894-7; PMID:15261186; http://dx.doi.org/10.1016/j.healun.2003.07.018
   PubMed Web of Science ®Google Scholar
• Zard E, Arnaud L, Mathian A, Chakhtoura Z, Hie M, Touraine P, Heard I, Amoura Z. Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: a meta-analysis of the literature. Autoimmun Rev Jul 2014; 13(7):730-5; PMID:24657969; http://dx.doi.org/10.1016/j.autrev.2014.03.001
   PubMed Web of Science ®Google Scholar
• de Araujo MR, Rubira-Bullen IR, Santos CF, Dionísio TJ, Bonfim CM, De Marco L, Gillio-Tos A, Merletti F. High prevalence of oral human papillomavirus infection in Fanconi's anemia patients. Oral Dis. Sep 2011; 17(6):572-6; PMID:21332606; http://dx.doi.org/10.1111/j.1601-0825.2011.01803.x
   PubMed Web of Science ®Google Scholar
• Denny LA, Franceschi S, de Sanjose S, Heard I, Moscicki AB, Palefsky J. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine Nov 20 2012; 30 Suppl 5:F168-74; PMID:23199960; http://dx.doi.org/10.1016/j.vaccine.2012.06.045
   PubMedGoogle Scholar
• Nath R, Mant C, Luxton J, Hughes G, Raju KS, Shepherd P, Cason J. High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthr Rheu. May 15 2007; 57(4):619-25; PMID:17471531; http://dx.doi.org/10.1002/art.22667
   PubMed Web of Science ®Google Scholar
• Tam LS, Chan PK, Ho SC, Yu MM, Yim SF, Cheung TH, Wong MC, Li EK. Natural history of cervical papilloma virus infection in systemic lupus erythematosus – a prospective cohort study. J Rheumatol Feb 2010; 37(2):330-40; PMID:20032093; http://dx.doi.org/10.3899/jrheum.090644
   PubMed Web of Science ®Google Scholar
• Dreyer L, Faurschou M, Mogensen M, Jacobsen S. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort. Arthr Rheu Oct 2011; 63(10):3032-7; PMID:21953088; http://dx.doi.org/10.1002/art.30483
   PubMed Web of Science ®Google Scholar
• Klumb EM, Pinto AC, Jesus GR, Araujo M Jr, Jascone L, Gayer CR, Ribeiro FM, Albuquerque EM, Macedo JM. Are women with lupus at higher risk of HPV infection? Lupus Nov 2010; 19(13):1485-91; PMID:20605875; http://dx.doi.org/10.1177/0961203310372952
   PubMed Web of Science ®Google Scholar
• Levin MJ, Moscicki AB, Song LY, Fenton T, Meyer WA 3rd, Read JS, Handelsman EL, Nowak B, Sattler CA, Saah A, et al. Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old. J Acq Immune Def Synd Oct 2010; 55(2):197-204; PMID:20574412; http://dx.doi.org/10.1097/QAI.0b013e3181de8d26
   PubMed Web of Science ®Google Scholar
• Kahn JA, Xu J, Kapogiannis BG, Rudy B, Gonin R, Liu N, Wilson CM, Worrell C, Squires KE. Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis : Off Pub Infect Dis Soc Am Sep 2013; 57(5):735-44; PMID:23667266; http://dx.doi.org/10.1093/cid/cit319
   PubMed Web of Science ®Google Scholar
• Soybilgic A, Onel KB, Utset T, Alexander K, Wagner-Weiner L. Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years. Pediat Rheumatol Online J 2013; 11:29; PMID:23924237; http://dx.doi.org/10.1186/1546-0096-11-29
   PubMed Web of Science ®Google Scholar
• Mok CC, Ho LY, Fong LS, To CH. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study. Ann Rheu Dis May 2013; 72(5):659-64; PMID:22589375; http://dx.doi.org/10.1136/annrheumdis-2012-201393
   PubMed Web of Science ®Google Scholar
• Dobson SR, McNeil S, Dionne M, Dawar M, Ogilvie G, Krajden M, Sauvageau C, Scheifele DW, Kollmann TR, Halperin SA, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA May 1 2013; 309(17):1793-802; PMID:23632723; http://dx.doi.org/10.1001/jama.2013.1625
   PubMed Web of Science ®Google Scholar
• Romanowski B, Schwarz TF, Ferguson LM, Ferguson M, Peters K, Dionne M, Schulze K, Ramjattan B, Hillemanns P, Behre U, et al. Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: results from a randomized study. Hum Vaccin Immunother May 2014; 10(5):1155-65; PMID:24576907; http://dx.doi.org/10.4161/hv.28022
   PubMed Web of Science ®Google Scholar
• Hoffman L, Okcu MF, Dreyer ZE, Suzawa H, Bryant R, Middleman AB. Human papillomavirus vaccination in female pediatric cancer survivors. J Pediatr Adolesc Gynecol Oct 2012; 25(5):305-7; PMID:22831900; http://dx.doi.org/10.1016/j.jpag.2012.05.004
   PubMed Web of Science ®Google Scholar
• Klosky JL, Russell KM, Canavera KE, Gammel HL, Hodges JR, Foster RH, Parra GR, Simmons JL, Green DM, Hudson MM. Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer. Cancer Prevent Res Oct 2013; 6(10):1101-10; PMID:23983087; http://dx.doi.org/10.1158/1940-6207.CAPR-13-0127
   PubMed Web of Science ®Google Scholar
• Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Mar 24 2006; 55(RR-3):1-34
   PubMedGoogle Scholar
• Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations. Vaccine Jul 27 2012; 30(35):5179-90; PMID:22709953; http://dx.doi.org/10.1016/j.vaccine.2012.06.005
   PubMed Web of Science ®Google Scholar
• Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, Martin SW. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. Jama Nov 28 2012; 308(20):2126-32; PMID:23188029; http://dx.doi.org/10.1001/jama.2012.14939
   PubMed Web of Science ®Google Scholar
• World Health Organization. Tetanus vaccine: WHO position paper, May 2006. Weekly Epidemiol Rec 2006; 81 (20):197-208; PMID:16710949
   PubMedGoogle Scholar
• World Health Organization. Pertussis vaccine: WHO position paper, October 2010. Weekly Epidemiol Rec 2010; 85(40):385-400
   PubMedGoogle Scholar
• Chaves TS, Pereira LM, De Santos SS, David-Neto E, Lopes MH. Evaluation of the vaccination status in pediatric renal transplant recipients. Pediatr Transplant Jun 2008; 12(4):432-5; PMID:18466429; http://dx.doi.org/10.1111/j.1399-3046.2007.00820.x
   PubMed Web of Science ®Google Scholar
• Pandolfi E, Carloni E, Marino MG, Ciofi degli Atti ML, Gesualdo F, Romano M, Giannattasio A, Guarino A, Carloni R, Borgia P, et al. Immunization coverage and timeliness of vaccination in Italian children with chronic diseases. Vaccine Mar 25 2012; 30(34):5172-78; PMID:21414380; http://dx.doi.org/10.1016/j.vaccine.2011.02.099
   PubMed Web of Science ®Google Scholar
• Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Mar 22 2013; 62(RR-2):1-28
   PubMedGoogle Scholar
• World Health Organization. Meningococcal vaccines: WHO position paper, November 2011. Weekly Epidemiol Rec 2011; 86 (47):521-40
   PubMedGoogle Scholar
• World Health Organization. Meningococcal A conjugate vaccine: updated guidance, February 2015. Weekly Epidemiol Rec 2015; 90(8):57-68
   PubMedGoogle Scholar
• Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev Jul 1991; 4(3):359-95; PMID:1889047
   PubMed Web of Science ®Google Scholar
• Jenco M. ACIP approves meningitis vaccines for high-risk patients. AAP News http://aapnews.aappublications.org/content/early/2015/03/02/aapnews.20150302-1.full.pdf+html. Accessed 1 June 2015
   Google Scholar
• Balmer P, Falconer M, McDonald P, Andrews N, Fuller E, Riley C, Kaczmarski E, Borrow R. Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals. Infect Immun Jan 2004; 72(1):332-7; PMID:14688112; http://dx.doi.org/10.1128/IAI.72.1.332-337.2004
   PubMed Web of Science ®Google Scholar
• Siberry GK, Williams PL, Lujan-Zilbermann J, Warshaw MG, Spector SA, Decker MD, Heckman BE, Demske EF, Read JS, Jean-Philippe P, et al. Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents. Pediat Infect Dis J May 2010; 29(5):391-6; PMID:20431379; http://dx.doi.org/10.1097/INF.0b013e3181c38f3b
   PubMed Web of Science ®Google Scholar
• Keyserling H, Papa T, Koranyi K, Ryall R, Bassily E, Bybel MJ, Sullivan K, Gilmet G, Reinhardt A. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents. Arch Pediat Adolesc Med Oct 2005; 159(10):907-13; PMID:16203934; http://dx.doi.org/10.1001/archpedi.159.10.907
   PubMed Web of Science ®Google Scholar
• Gill CJ, Baxter R, Anemona A, Ciavarro G, Dull P. Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo(R)) or Menactra(R) among healthy adolescents. Hum Vaccines Nov 2010; 6(11):881-7; PMID:21339701; http://dx.doi.org/10.4161/hv.6.11.12849
   PubMed Web of Science ®Google Scholar
• Macneil JR, Cohn AC, Zell ER, Schmink S, Miller E, Clark T, Messonnier NE, Active Bacterial Core surveillance (ABCs) Team and MeningNet Surveillance Partners. Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine. Pediat Infect Dis J Jun 2011; 30(6):451-5; PMID:21206392
   PubMed Web of Science ®Google Scholar
• Fernandez-Ibieta M, Ramos-Amador JT, Aunon-Martin I. HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study. Int J STD & AIDS May 2007; 18(5):351-3; PMID:17524201; http://dx.doi.org/10.1258/095646207780749763
   PubMed Web of Science ®Google Scholar
• Cano R, Larrauri A, Mateo S, Alcala B, Salcedo C, Vazquez JA. Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision. Euro Surveillance: Bull Eur Sur les Maladies Transmissibles = Eur Communicable Dis Bull Jul 2004; 9(7):11-5
   PubMedGoogle Scholar
• World Health Organization. Vaccines against influenza: WHO position paper, November 2012. Weekly Epidemiol Rec 2012; 87(47):461-76
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices–United States, 2013-2014. MMWR Sep 20 2013; 62(RR-07):1-43
   PubMedGoogle Scholar
• Monto AS, Kioumehr F. The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966–1971. Am J Epidemiol Dec 1975; 102(6):553-63; PMID:1202957
   PubMed Web of Science ®Google Scholar
• Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA Jan 26 2000; 283(4):499-05; PMID:10659876; http://dx.doi.org/10.1001/jama.283.4.499
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Wright PF, Mitchel EF, Jr., Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr Dec 2000; 137(6):856-64; PMID:11113844; http://dx.doi.org/10.1067/mpd.2000.110445
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Severe influenza among children and young adults with neurologic and neurodevelopmental conditions – Ohio, 2011. MMWR Morb Mortal Wkly Rep Jan 6 2012; 60(51-52):1729-33; PMID:22217621
   PubMedGoogle Scholar
• Keren R, Zaoutis TE, Bridges CB, Herrera G, Watson BM, Wheeler AB, Licht DJ, Luan XQ, Coffin SE. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA Nov 2 2005; 294(17):2188-94; PMID:16264160; http://dx.doi.org/10.1001/jama.294.17.2188
   PubMed Web of Science ®Google Scholar
• Randolph AG, Vaughn F, Sullivan R, Rubinson L, Thompson BT, Yoon G, Smoot E, Rice TW, Loftis LL, Helfaer M, et al. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics Dec 2011; 128(6):e1450-8; PMID:22065262; http://dx.doi.org/10.1542/peds.2011-0774
   PubMedGoogle Scholar
• Groothuis JR, Lehr MV, Levin MJ. Safety and immunogenicity of a purified haemagglutinin antigen in very young high-risk children. Vaccine Feb 1994; 12(2):139-41; PMID:8147095; http://dx.doi.org/10.1016/0264-410X(94)90051-5
   PubMed Web of Science ®Google Scholar
• Long CB, Ramos I, Rastogi D, Manwani D, Janow G, Del Rio M, Mayers M, Herold BC, Fernandez-Sesma A, et al. Humoral and cell-mediated immune responses to monovalent 2009 influenza A/H1N1 and seasonal trivalent influenza vaccines in high-risk children. J Pediat Jan 2012; 160(1):74-81; PMID:21840537; http://dx.doi.org/10.1016/j.jpeds.2011.06.045
   PubMed Web of Science ®Google Scholar
• Meier S, Bel M, L'Huillier A, Crisinel PA, Combescure C, Kaiser L, Grillet S, Pósfay-Barbe K, Siegrist CA, H1N1 Epidemiology Study Group of Geneva. Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children. Vaccine Apr 27 2011; 29(19):3548-57; PMID:21419775; http://dx.doi.org/10.1016/j.vaccine.2011.02.094
   PubMed Web of Science ®Google Scholar
• Glezen WP, Glezen LS, Alcorn R. Trivalent, inactivated influenza virus vaccine in children with sickle cell disease. Am J Dis Children Nov 1983; 137(11):1095-7
   PubMedGoogle Scholar
• Grohskopf LA, Olsen SJ, Sokolow LZ, Bresee JS, Cox NJ, Broder KR, Karron RA, Walter EB, Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) – United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep Aug 15 2014; 63(32):691-7; PMID:25121712
   PubMed Web of Science ®Google Scholar
• Nakamura MM, Lee GM. Influenza vaccination in adolescents with high-risk conditions. Pediatrics Nov 2008; 122(5):920-8; PMID:18977969; http://dx.doi.org/10.1542/peds.2007-3032
   PubMed Web of Science ®Google Scholar
• Lin CJ, Nowalk MP, Zimmerman RK, Ko FS, Zoffel L, Hoberman A, Kearney DH. Beliefs and attitudes about influenza immunization among parents of children with chronic medical conditions over a two-year period. J Urban Health Sep 2006; 83(5):874-83; PMID:16770701; http://dx.doi.org/10.1007/s11524-006-9084-z
   PubMed Web of Science ®Google Scholar
• Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep Aug 6 2010; 59(RR-8):1-62; PMID:20689501
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Vaccination coverage among persons with asthma – United States, 2010-2011 influenza season. MMWR Morb Mortal Wkly Rep Dec 6 2013; 62(48):973-8; PMID:24304828
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Influenza vaccination practices of physicians and caregivers of children with neurologic and neurodevelopmental conditions – United States, 2011-12 influenza season. MMWR Morb Mortal Wkly Rep Sep 13 2013; 62(36):744-6; PMID:24025756
   PubMed Web of Science ®Google Scholar
• Gnanasekaran SK, Finkelstein JA, Lozano P, Farber HJ, Chi FW, Lieu TA. Influenza vaccination among children with asthma in medicaid managed care. Ambul Pediatr Jan-Feb 2006; 6(1):1-7; PMID:16443176; http://dx.doi.org/10.1016/j.ambp.2005.08.004
   PubMedGoogle Scholar
• Marshall BC, Henshaw C, Evans DA, Bleyl K, Alder S, Liou TG. Influenza vaccination coverage level at a cystic fibrosis center. Pediatrics May 2002; 109(5):E80-0; PMID:11986486; http://dx.doi.org/10.1542/peds.109.5.e80
   PubMedGoogle Scholar
• Ortiz JR, Neuzil KM, Victor JC, Aitken ML, Goss CH. Predictors of influenza vaccination in the Cystic Fibrosis Foundation patient registry, 2006 through 2007. Chest Dec 2010; 138(6):1448-55; PMID:20495106; http://dx.doi.org/10.1378/chest.10-0356
   PubMed Web of Science ®Google Scholar
• Esposito S, Mastrolia MV, Prada E, Pietrasanta C, Principi N. Vaccine administration in children with chronic kidney disease. Vaccine Nov 20 2014; 32(49):6601-6; PMID:25275950; http://dx.doi.org/10.1016/j.vaccine.2014.09.038
   PubMed Web of Science ®Google Scholar
• Tillmann BU, Tillmann HC, Heininger U, Lutschg J, Weber P. Acceptance and timeliness of standard vaccination in children with chronic neurological deficits in north-western Switzerland. Eur J Pediat May 2005; 164(5):320-5; PMID:15731906; http://dx.doi.org/10.1007/s00431-005-1627-x
   PubMed Web of Science ®Google Scholar
• Joseph C, Goddard N, Gelb D. Influenza vaccine uptake and distribution in England and Wales using data from the General Practice Research Database, 1989/90-2003/04. J Public Health Dec 2005; 27(4):371-7; PMID:16207735; http://dx.doi.org/10.1093/pubmed/fdi054
   PubMed Web of Science ®Google Scholar
• Sammon CJ, McGrogan A, Snowball J, de Vries CS. Factors associated with uptake of seasonal and pandemic influenza vaccine among clinical risk groups in the UK: an analysis using the General Practice Research Database. Vaccine Mar 23 2012; 30(14):2483-9; PMID:22133511; http://dx.doi.org/10.1016/j.vaccine.2011.11.077
   PubMed Web of Science ®Google Scholar
• Giannattasio A, Squeglia V, Lo Vecchio A, Russo MT, Barbarino A, Carlomagno R, Guarino A. Pneumococcal and influenza vaccination rates and their determinants in children with chronic medical conditions. Ital J Pediatr 2010; 36:28; PMID:20346141; http://dx.doi.org/10.1186/1824-7288-36-28
   PubMed Web of Science ®Google Scholar
• Camurdan MO, Camurdan AD, Beyazova U, Bideci A. The rate of seasonal influenza vaccination in diabetic children, the effect of recommendation and the factors influencing the acceptance of recommendation: an interventional study. Balkan Med J Dec 2012; 29(4):434-9; PMID:25207049
   PubMedGoogle Scholar
• Zerr DM, Englund JA, Robertson AS, Marcuse EK, Garrison MM, Christakis DA. Hospital-based influenza vaccination of children: an opportunity to prevent subsequent hospitalization. Pediatrics Feb 2008; 121(2):345-8; PMID:18245426; http://dx.doi.org/10.1542/peds.2007-2812
   PubMed Web of Science ®Google Scholar
• World Health Organization. Pneumococcal vaccines: WHO position paper, November 2012. Weekly Epidemiol Rec 2012; 87(14):129-44
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep Jun 28 2013; 62(25):521-4; PMID:23803961
   PubMed Web of Science ®Google Scholar
• De Montalembert M, Abboud MR, Fiquet A, De Montalembert M, Abboud MR, Fiquet A, Inati A, Lebensburger JD, Kaddah N, Mokhtar G, et al. 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): results of a phase 3 study. Pediat Blood & Cancer Mar 23 2015; PMID:25810327
   PubMed Web of Science ®Google Scholar
• Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis Feb 2005; 5(2):83-93; PMID:15680778; http://dx.doi.org/10.1016/S1473-3099(05)70083-9
   PubMed Web of Science ®Google Scholar
• Yildirim I, Shea KM, Little BA, Silverio AL, Pelton SI, on behalf of the Members of the Massachusetts Department of Public H. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease. Pediatrics Feb 2 2015; PMID:25647674
   PubMed Web of Science ®Google Scholar
• Fiore AE, Levine OS, Elliott JA, Facklam RR, Butler JC. Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease. Emerg Infect Dis Nov-Dec 1999; 5(6):828-31; PMID:10603221; http://dx.doi.org/10.3201/eid0506.990616
   PubMed Web of Science ®Google Scholar
• Bolan G, Broome CV, Facklam RR, Plikaytis BD, Fraser DW, Schlech WF 3rd. Pneumococcal vaccine efficacy in selected populations in the United States. Ann Int Med Jan 1986; 104(1):1-6; PMID:3940476; http://dx.doi.org/10.7326/0003-4819-104-1-1
   PubMed Web of Science ®Google Scholar
• Borrow R, Heath PT, Siegrist CA. Use of pneumococcal polysaccharide vaccine in children: what is the evidence? Curr Opin Infect Dis Jun 2012; 25(3):292-303; PMID:22517603; http://dx.doi.org/10.1097/QCO.0b013e3283531b0f
   PubMed Web of Science ®Google Scholar
• Abzug MJ, Pelton SI, Song LY, Fenton T, Levin MJ, Nachman SA, Borkowsky W, Rosenblatt HM, Marcinak JF, Dieudonne A, et al. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediat Infect Dis J Oct 2006; 25(10):920-9; PMID:17006288; http://dx.doi.org/10.1097/01.inf.0000237830.33228.c3
   PubMed Web of Science ®Google Scholar
• 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Releve Epidemiol Hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations Oct 17 2008; 83(42):373-84
   PubMedGoogle Scholar
• Nero AC, Akuete K, Leasure Reeves S, Dombkowski KJ. Pneumococcal vaccination rates in children with sickle cell disease. J Public Health Manage Practice: JPHMP Nov-Dec 2014; 20(6):587-90; PMID:24253403; http://dx.doi.org/10.1097/PHH.0000000000000034
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19-35 months – United States, 2008. MMWR Morb Mortal Wkly Rep Aug 28 2009; 58(33):921-6; PMID:19713881
   PubMedGoogle Scholar
• Ou H, Cleary P, Sie K. Assessing the immunization status of pediatric cochlear implant recipients using a state-maintained immunization registry. Otolaryngol–Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg Oct 2010; 143(4):487-91; PMID:20869556; http://dx.doi.org/10.1016/j.otohns.2010.05.020
   PubMed Web of Science ®Google Scholar
• Pebody RG, Hippisley-Cox J, Harcourt S, Pringle M, Painter M, Smith G. Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005. Epidemiol Infect Mar 2008; 136(3):360-9; PMID:17445314; http://dx.doi.org/10.1017/S0950268807008436
   PubMed Web of Science ®Google Scholar
• Suris JC, Michaud PA, Akre C, Sawyer SM. Health risk behaviors in adolescents with chronic conditions. Pediatrics Nov 2008; 122(5):e1113-8; PMID:18977960; http://dx.doi.org/10.1542/peds.2008-1479
   PubMed Web of Science ®Google Scholar
• Choquet M, Du Pasquier Fediaevsky L, Manfredi R. Sexual behavior among adolescents reporting chronic conditions: a French national survey. J Adolesc Health: Off Pub Soc Adolesc Med Jan 1997; 20(1):62-7; PMID:9007661; http://dx.doi.org/10.1016/S1054-139X(96)00091-2
   PubMed Web of Science ®Google Scholar
• Britto MT, Garrett JM, Dugliss MA, Daeschner CW Jr, Johnson CA, Leigh MW, Majure JM, Schultz WH, Konrad TR. Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter study. Pediatrics Feb 1998; 101(2):250-6; PMID:9445499; http://dx.doi.org/10.1542/peds.101.2.250
   PubMed Web of Science ®Google Scholar
• Britto MT, Garrett JM, Dugliss MA, Johnson CA, Majure JM, Leigh MW. Preventive services received by adolescents with cystic fibrosis and sickle cell disease. Arch Pediat Adolesc Med Jan 1999; 153(1):27-32
   PubMed Web of Science ®Google Scholar
• Britto MT, DeVellis RF, Hornung RW, DeFriese GH, Atherton HD, Slap GB. Health care preferences and priorities of adolescents with chronic illnesses. Pediatrics Nov 2004; 114(5):1272-80; PMID:15520107; http://dx.doi.org/10.1542/peds.2003-1134-L
   PubMed Web of Science ®Google Scholar
• Walter EB, Kemper AR, Dolor RJ, Dunne EF. Pain in adolescent girls receiving HPV vaccine with concomitantly administered vaccines. Pediat Infect Dis J Feb 2015; 34(2):200-2; PMID:25222307
   PubMed Web of Science ®Google Scholar
• Seale H, Trung L, Mackie FE, Kennedy SE, Boros C, Marshall H, Tidswell J, Shaw PJ, Montgomery K, MacIntyre CR. A qualitative study investigating knowledge and attitudes regarding human papillomavirus (HPV) and the HPV vaccine among parents of immunosuppressed children. Vaccine Nov 19 2012; 30(49):7027-31; PMID:23059356; http://dx.doi.org/10.1016/j.vaccine.2012.09.066
   PubMed Web of Science ®Google Scholar
• Esposito S, Marchisio P, Droghetti R, Lambertini L, Faelli N, Bosis S, Tosi S, Begliatti E, Principi N. Influenza vaccination coverage among children with high-risk medical conditions. Vaccine Jun 12 2006; 24(24):5251-5; PMID:16621177; http://dx.doi.org/10.1016/j.vaccine.2006.03.059
   PubMed Web of Science ®Google Scholar
• Daley MF, Beaty BL, Barrow J, Pearson K, Crane LA, Berman S, Kempe A. Missed opportunities for influenza vaccination in children with chronic medical conditions. Arch Ped Adolesc Med Oct 2005; 159(10):986-91; PMID:16203946; http://dx.doi.org/10.1001/archpedi.159.10.986
   PubMed Web of Science ®Google Scholar
• Sampson R, Wong L, Macvicar R. Parental reasons for non-uptake of influenza vaccination in young at-risk groups: a qualitative study. Brit J Gen Practice: J Royal College of Gen Pract Jul 2011; 61(588):e386-91; PMID:21722445; http://dx.doi.org/10.3399/bjgp11X583155
   PubMedGoogle Scholar
• Gnanasekaran SK, Finkelstein JA, Hohman K, O'Brien M, Kruskal B, Lieu T. Parental perspectives on influenza vaccination among children with asthma. Public Health Rep Mar-Apr 2006; 121(2):181-8; PMID:16528952
   PubMed Web of Science ®Google Scholar
• Mirza A, Subedar A, Fowler SL, Murray DL, Arnold S, Tristram D, Abuelreish M, Wludyka P, Chiu TT, Rathore MH. Influenza vaccine: awareness and barriers to immunization in families of children with chronic medical conditions other than asthma. South Med J Nov 2008; 101(11):1101-5; PMID:19088517; http://dx.doi.org/10.1097/SMJ.0b013e318182ee8d
   PubMed Web of Science ®Google Scholar
• Raddish M, Goldmann DA, Kaplan LC, Perrin JM. The immunization status of children with spina bifida. Am J Dis Children Aug 1993; 147(8):849-53
   PubMedGoogle Scholar
• Rickert D, Santoli J, Shefer A, Myrick A, Yusuf H. Influenza vaccination of high-risk children: what the providers say. Am J Prev Med Feb 2006; 30(2):111-8; PMID:16459208; http://dx.doi.org/10.1016/j.amepre.2005.10.016
   PubMed Web of Science ®Google Scholar
• Hofstetter AM, Rosenthal SL. Health care professional communication about STI vaccines with adolescents and parents. Vaccine Mar 20 2014; 32(14):1616-23; PMID:23791695; http://dx.doi.org/10.1016/j.vaccine.2013.06.035
   PubMed Web of Science ®Google Scholar
• Britto MT, Slap GB, DeVellis RF, Hornung RW, Atherton HD, Knopf JM, DeFriese GH. Specialists understanding of the health care preferences of chronically ill adolescents. J Adolesc Health: Off Pub Soc Adolesc Med Apr 2007; 40(4):334-41; PMID:17367726; http://dx.doi.org/10.1016/j.jadohealth.2006.10.020
   PubMed Web of Science ®Google Scholar
• Melmed GY, Ippoliti AF, Papadakis KA, Tran TT, Birt JL, Lee SK, Frenck RW, Targan SR, Vasiliauskas EA. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol Aug 2006; 101(8):1834-40; PMID:16817843; http://dx.doi.org/10.1111/j.1572-0241.2006.00646.x
   PubMed Web of Science ®Google Scholar
• Cecinati V, Esposito S, Scicchitano B, Delvecchio GC, Amato D, Pelucchi C, Jankovic M, De Mattia D, Principi N. Effectiveness of recall systems for improving influenza vaccination coverage in children with oncohematological malignancies. Hum Vaccin Feb 2010; 6(2):194-7; PMID:19946216; http://dx.doi.org/10.4161/hv.6.2.10253
   PubMed Web of Science ®Google Scholar
• Medical Home Initiatives for Children With Special Needs Project Advisory Committee. American Academy of P. The medical home. Pediatrics Jul 2002; 110(1 Pt 1):184-6; PMID:12093969
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Rand CM, McLaurin J, Tan L, Britto M, Francis A, Dunne E, Rickert D, Working Group on Adolescent Vaccination in the Medical Home. Delivering adolescent vaccinations in the medical home: a new era? Pediatrics Jan 2008; 121 Suppl 1:S15-24; PMID:18174317; http://dx.doi.org/10.1542/peds.2007-1115C
   PubMed Web of Science ®Google Scholar
• Sara Test F, Caskey R, Rankin KM. The relationship between receiving care within a medical home and HPV vaccine receipt for adolescent girls: results of the 2007 National Survey of Children's Health. Matern Child Health J Feb 2012; 17(2):274-81; PMID:22415810; http://dx.doi.org/10.1007/s10995-012-0975-1
   PubMed Web of Science ®Google Scholar
• Palfrey JS, Levy JC, Gilbert KL. Use of primary care facilities by patients attending specialty clinics. Pediatrics Mar 1980; 65(3):567-72; PMID:7360546
   PubMed Web of Science ®Google Scholar
• Carroll G, Massarelli E, Opzoomer A, Pekeles G, Pedneault M, Frappier JY, Onetto N. Adolescents with chronic disease. Are they receiving comprehensive health care? J Adolesc Health Care Dec 1983; 4(4):261-5; PMID:6643204; http://dx.doi.org/10.1016/S0197-0070(83)80008-4
   PubMedGoogle Scholar
• Boyce T, Holmes A. Addressing health inequalities in the delivery of the human papillomavirus vaccination programme: examining the role of the school nurse. PLoS One 2012; 7(9):e43416; PMID:23028452; http://dx.doi.org/10.1371/journal.pone.0043416
   PubMed Web of Science ®Google Scholar
• Newacheck PW, Hung YY, Wright KK. Racial and ethnic disparities in access to care for children with special health care needs. Ambul Pediatr Jul-Aug 2002; 2(4):247-54; PMID:12135397; http://dx.doi.org/10.1367/1539-4409(2002)002%3c0247:RAEDIA%3e2.0.CO;2
   PubMedGoogle Scholar
• Raphael JL, Zhang Y, Liu H, Tapia CD, Giardino AP. Association of medical home care and disparities in emergency care utilization among children with special health care needs. Acad Pediat Jul-Aug 2009; 9(4):242-8; PMID:19608125; http://dx.doi.org/10.1016/j.acap.2009.05.002
   PubMed Web of Science ®Google Scholar
• Bethell CD, Kogan MD, Strickland BB, Schor EL, Robertson J, Newacheck PW. A national and state profile of leading health problems and health care quality for US children: key insurance disparities and across-state variations. Acad Pediat May-Jun 2011; 11(3 Suppl):S22-33; PMID:21570014; http://dx.doi.org/10.1016/j.acap.2010.08.011
   PubMedGoogle Scholar
• Jacobson VJ, Szilagyi P. Patient reminder and patient recall systems to improve immunization rates. Cochrane Database Syst Rev 2005(3):CD003941; PMID:16034918
   PubMedGoogle Scholar
• Briss PA, Rodewald LE, Hinman AR, Shefer AM, Strikas RA, Bernier RR, Carande-Kulis VG, Yusuf HR, Ndiaye SM, Williams SM. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med Jan 2000; 18(1 Suppl):97-140; PMID:10806982; http://dx.doi.org/10.1016/S0749-3797(99)00118-X
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Albertin C, Humiston SG, Rand CM, Schaffer S, Brill H, Stankaitis J, Yoo BK, Blumkin A, Stokley S. A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents. Acad Pediatr May-Jun 2013; 13(3):204-13; PMID:23510607; http://dx.doi.org/10.1016/j.acap.2013.01.002
   PubMed Web of Science ®Google Scholar
• Chao C, Preciado M, Slezak J, Xu L. A randomized intervention of reminder letter for human papillomavirus vaccine series completion. J Adolesc Health Jan 2015; 56(1):85-90; PMID:25438965; http://dx.doi.org/10.1016/j.jadohealth.2014.08.014
   PubMed Web of Science ®Google Scholar
• Kharbanda EO, Stockwell MS, Fox HW, Andres R, Lara M, Rickert VI. Text message reminders to promote human papillomavirus vaccination. Vaccine Mar 21 2011; 29(14):2537-41; PMID:21300094; http://dx.doi.org/10.1016/j.vaccine.2011.01.065
   PubMed Web of Science ®Google Scholar
• Stockwell MS, Kharbanda EO, Andres R, Lara M, Vawdrey D, Natarajan K, Rickert VI. Text4Health: text message reminder-recalls to improve pediatric and adolescent immunizations. Am J Public Health 2012; 102(2):e15-21; PMID:22390457
   PubMedGoogle Scholar
• Matheson EC, Derouin A, Gagliano M, Thompson JA, Blood-Siegfried J. Increasing HPV vaccination series completion rates via text message reminders. J Pediat Health Care: Off Pub Natl Assoc Pediat Nurse Assoc Pract. Jul-Aug 2014; 28(4):e35-39; PMID:24200295; http://dx.doi.org/10.1016/j.pedhc.2013.09.001
   PubMedGoogle Scholar
• Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin A. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med Jun 2011; 165(6):547-53; PMID:21646588; http://dx.doi.org/10.1001/archpediatrics.2011.73
   PubMed Web of Science ®Google Scholar
• Fiks AG, Grundmeier RW, Mayne S, Song L, Feemster K, Karavite D, Hughes CC, Massey J, Keren R, Bell LM, et al. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics Jun 2013; 131(6):1114-24; PMID:23650297; http://dx.doi.org/10.1542/peds.2012-3122
   PubMed Web of Science ®Google Scholar
• Dombkowski KJ, Leung SW, Clark SJ. Provider attitudes regarding use of an immunization information system to identify children with asthma for influenza vaccination. J Public Health Manag Pract Nov-Dec 2007; 13(6):567-71; PMID:17984709; http://dx.doi.org/10.1097/01.PHH.0000296131.77637.1f
   PubMed Web of Science ®Google Scholar
• Daley MF, Barrow J, Pearson K, Crane LA, Gao D, Stevenson JM, Berman S, Kempe A. Identification and recall of children with chronic medical conditions for influenza vaccination. Pediatrics Jan 2004; 113(1 Pt 1):e26-33; PMID:14702491
   PubMedGoogle Scholar
• Dombkowski KJ, Harrington LB, Dong S, Clark SJ. Seasonal influenza vaccination reminders for children with high-risk conditions a registry-based randomized trial. Am J Prev Med Jan 2012; 42(1):71-5; PMID:22176850; http://dx.doi.org/10.1016/j.amepre.2011.09.028
   PubMed Web of Science ®Google Scholar
• Esposito S, Pelucchi C, Tel F, Chiarelli G, Sabatini C, Semino M, Marseglia GL, De Mattia D, Principi N. Factors conditioning effectiveness of a reminder/recall system to improve influenza vaccination in asthmatic children. Vaccine Jan 29 2009; 27(5):633-5; PMID:19056445; http://dx.doi.org/10.1016/j.vaccine.2008.11.043
   PubMed Web of Science ®Google Scholar
• Murray E, Burns J, See TS, Lai R, Nazareth I. Interactive Health Communication Applications for people with chronic disease. Cochrane Database Syst Rev 2005(4):CD004274; PMID:16235356
   PubMed Web of Science ®Google Scholar
• Shah S, Peat JK, Mazurski EJ, Wang H, Sindhusake D, Bruce C, Henry RL, Gibson PG. Effect of peer led programme for asthma education in adolescents: cluster randomised controlled trial. Bmj Mar 10 2001; 322(7286):583-5; PMID:11238152; http://dx.doi.org/10.1136/bmj.322.7286.583
   PubMed Web of Science ®Google Scholar
• Britto MT, Hesse EA, Kamdar OJ, Munafo JK. Parents' perceptions of a patient portal for managing their child's chronic illness. J Pediat Jul 2013; 163(1):280-1 e281-282; PMID:23541773; http://dx.doi.org/10.1016/j.jpeds.2013.02.041
   PubMed Web of Science ®Google Scholar
• Kitayama K, Stockwell MS, Vawdrey DK, Pena O, Catallozzi M. Parent perspectives on the design of a personal online pediatric immunization record. Clin Pediat Mar 2014; 53(3):238-42; PMID:24137033; http://dx.doi.org/10.1177/0009922813506608
   PubMed Web of Science ®Google Scholar
• Mayne SL, duRivage NE, Feemster KA, Localio AR, Grundmeier RW, Fiks AG. Effect of decision support on missed opportunities for human papillomavirus vaccination. Am J Prev Med Dec 2014; 47(6):734-44; PMID:25455116; http://dx.doi.org/10.1016/j.amepre.2014.08.010
   PubMed Web of Science ®Google Scholar
• Stockwell MS, Catallozzi M, Camargo S, Ramakrishnan R, Holleran S, Findley SE, Kukafka R, Hofstetter AM, Fernandez N, Vawdrey DK. Registry-linked electronic influenza vaccine provider reminders: a cluster-crossover trial. Pediatrics Jan 2015; 135(1):e75-82; PMID:25548331; http://dx.doi.org/10.1542/peds.2014-2616
   PubMed Web of Science ®Google Scholar
• Fiks AG, Hunter KF, Localio AR, Grundmeier RW, Bryant-Stephens T, Luberti AA, Bell LM, Alessandrini EA. Impact of electronic health record-based alerts on influenza vaccination for children with asthma. Pediatrics Jul 2009; 124(1):159-69; PMID:19564296; http://dx.doi.org/10.1542/peds.2008-2823
   PubMed Web of Science ®Google Scholar
• Patwardhan A, Kelleher K, Cunningham D, Menke J, Spencer C. The use of a mandatory best practice reminder in the electronic record improves influenza vaccination rate in a pediatric rheumatology clinic. Clin Gov 2011; 16(4):308-19; http://dx.doi.org/10.1108/14777271111175350
   Google Scholar
• Britto MT, Schoettker PJ, Pandzik GM, Weiland J, Mandel KE. Improving influenza immunisation for high-risk children and adolescents. Quality & Safety Health Care Oct 2007; 16(5):363-8; PMID:17913778; http://dx.doi.org/10.1136/qshc.2006.019380
   PubMed Web of Science ®Google Scholar
• Rand CM, Szilagyi PG, Yoo BK, Auinger P, Albertin C, Coleman MS. Additional visit burden for universal influenza vaccination of US school-aged children and adolescents. Arch Pediatr Adolesc Med Nov 2008; 162(11):1048-55; PMID:18981353; http://dx.doi.org/10.1001/archpedi.162.11.1048
   PubMed Web of Science ®Google Scholar
• Basco WT, Jr., Recknor JC, Darden PM. Who needs an immunization in a pediatric subspecialty clinic? Arch Pediat Adolesc Med May 1996; 150(5):508-11; PMID:8620233; http://dx.doi.org/10.1001/archpedi.1996.02170300062012
   PubMed Web of Science ®Google Scholar
• Kharbanda EO, Stockwell MS, Colgrove J, Natarajan K, Rickert VI. Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade. Am J Public Health Sep 2010; 100(9):1635-40; PMID:20634463; http://dx.doi.org/10.2105/AJPH.2009.179341
   PubMed Web of Science ®Google Scholar